Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain

被引:73
作者
Serkova, N
Jacobsen, W
Niemann, CU
Litt, L
Benet, LZ
Leibfritz, D
Christians, U
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol, Denver, CO 80262 USA
[2] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA
[3] Univ Bremen, Inst Biol Chem, D-28359 Bremen, Germany
[4] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
关键词
cyclosporine toxicity; sirolimus; everolimus; SDZ-RAD; pharmacodynamic drug interactions; tissue distribution; brain metabolism; mitochondrial glucose metabolism; oxidative phosphorylation; magnetic resonance spectroscopy (MRS);
D O I
10.1038/sj.bjp.0704142
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Clinical studies have shown enhancement of cyclosporine toxicity when co-administered with the immunosuppressant sirolimus. We evaluated the biochemical mechanisms underlying the sirolimus/ cyclosporine interaction on rat brain metabolism using magnetic resonance spectroscopy (MRS) and compared the effects of sirolimus with those of the structurally related RAD. 2 Two-week-old rats (25 g) were allocated to the following treatment groups (all n=6): I. control, II. cyclosporine (10 mg kg(-1) d(-1)), III. sirolimus (3 mg kg(-1) d(-1)), IV. RAD (3 mg kg(-1) d(-1)), V. cyclosporine + sirolimus and VI. cyclosporine + RAD. Drugs were administered by oral gavage for 6 days. Twelve hours after the last dose, metabolic changes were assessed in brain tissue extracts using multinuclear MRS. 3 Cyclosporine significantly inhibited mitochondrial glucose metabolism (glutamate: 78 +/- 6% of control; GABA: 67 +/- 12%; NAD(+): 76 +/- 3%; P <0.05), but increased lactate production. Sirolimus and RAD inhibited cytosolic glucose metabolism via lactate production (sirolimus: 81 +/- 3% of control, RAD: 69 +/- 2%; P <0.02). Sirolimus enhanced cyclosporine-induced inhibition of mitochondrial glucose metabolism (glutamate: 60 +/- 4%; GABA: 59 +/- 8%; NAD(+): 45 +/- 5%; P <0.02 versus cyclosporine alone). Lactate production was significantly reduced. In contrast, RAD antagonized the effects of cyclosporine (glutamate, GABA, and NAD(+), not significantly different from controls). 4 The results can partially be explained by pharmacokinetic interactions: co-administration increased the distribution of cyclosporine and sirolimus into brain tissue, while co-administration with RAD decreased cyclosporine brain tissue concentrations. In addition RAD, but not sirolimus, distributed into brain mitochondria. 5 The combination of cyclosporine/RAD compares favourably to cyclosporinelsirolimus in regards to their effects on brain high-energy metabolism and tissue distribution in the rat.
引用
收藏
页码:875 / 885
页数:11
相关论文
共 41 条
[1]   Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model [J].
Andoh, TF ;
Lindsley, J ;
Franceschini, N ;
Bennett, WM .
TRANSPLANTATION, 1996, 62 (03) :311-316
[2]   DOES IMPAIRMENT OF ENERGY-METABOLISM RESULT IN EXCITOTOXIC NEURONAL DEATH IN NEURODEGENERATIVE ILLNESSES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1992, 31 (02) :119-130
[3]   Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin) [J].
Brattström, C ;
Wilczek, H ;
Tydén, G ;
Böttiger, Y ;
Säwe, J ;
Groth, CG .
TRANSPLANTATION, 1998, 65 (09) :1272-1274
[4]  
CALNE RY, 1979, LANCET, V2, P1033
[5]   Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants [J].
Christians, U ;
Jacobsen, W ;
Serkova, N ;
Benet, LZ ;
Vidal, C ;
Sewing, KF ;
Manns, MP ;
Kirchner, GI .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 748 (01) :41-53
[6]  
Crowe A, 1999, DRUG METAB DISPOS, V27, P627
[7]   In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats:: Comparison with rapamycin [J].
Crowe, A ;
Lemaire, M .
PHARMACEUTICAL RESEARCH, 1998, 15 (11) :1666-1672
[8]   REGULATION OF CELLULAR-ENERGY METABOLISM [J].
ERECINSKA, M ;
WILSON, DF .
JOURNAL OF MEMBRANE BIOLOGY, 1982, 70 (01) :1-14
[9]   CYCLOSPORINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN IMMUNOREGULATORY DISORDERS [J].
FAULDS, D ;
GOA, KL ;
BENFIELD, P .
DRUGS, 1993, 45 (06) :953-1040
[10]   The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans [J].
Gabe, SM ;
Bjarnason, I ;
Tolou-Ghamari, Z ;
Tredger, JM ;
Johnson, PG ;
Barclay, GR ;
Williams, R ;
Silk, DBA .
GASTROENTEROLOGY, 1998, 115 (01) :67-74